A year after we interviewed her at ENDO 2018, we talk again with Stephanie Page, MD, PhD, from University of Washington, about her continuing research on a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

As part of Women’s Health Month, we speak with Jerilynn Prior, who talks about a new treatment approach to perimenopause: oral, micronized progesterone. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk about nuclear receptor biology with Laurel Coons, first author of an Endocrinology article on hormone-mediated enhancer activation. The Endocrine Society is a sponsor of the upcoming Great Lakes Nuclear Receptor Conference in Minneapolis and is excited to share this nuclear receptor focused interview with you. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about thyroiditis and COVID-19 with Ilaria Muller, MD, PhD, from the University of Milan. Dr. Muller presented her research in March at ENDO 2021: “Early Follow-up of Atypical Thyroiditis Induced by SARS-CoV-2.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks more with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. Dr. Joseph talks about disparities in research funding and the need for mentoring for young researchers, changes in policymaking that helps poor and BIPOC communities, and more engagement by endocrinologists both in the pandemic and in the treatment of all communities. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Caitlin talks with author and researcher Nayara Aquino, PhD, from the Federal University of Minas Gerais, Brazil, about her research on neuroendocrine control of the female reproductive system. Her paper, published in Endocrinology in June 2017, was selected for the Endocrine Society’s Women in Endocrinology Thematic Issue. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk about diabetes and cancer with Anupam Kotwal, endocrinology fellow at the Mayo Clinic. His research shows the potential for autoimmune diabetes outcomes from novel anti-cancer agents. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

A new study in The Journal of Clinical Endocrinology & Metabolism shows the relationship between abnormal sodium levels and greater risk of respiratory failure and death in patients with COVID-19. Host Aaron Lohr speaks with two of the authors, Ploutarchos Tzoulis, MD, PhD, from University College London Medical School and Julian Waung, PhD, from the Whittington Health NHS Trust in London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We explore type 1 diabetes, everything from diagnosis to treatment strategies, hypoglycemia, technology, and teleheath. Host Aaron Lohr talks with Irl Hirsch, MD, from the University of Washington, and Davida Kruger, NP, from the Henry Ford Health System. They co-chair the Endocrine Society's 8th Annual Endocrine Fellows Type 1 Diabetes Care and Management Program. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Aaron talks with Deborah Kurrasch, PhD, associate professor at the University of Calgary, and Dinu Nesan, PhD, postdoctoral fellow also at University of Calgary. At the Endocrine Society's annual meeting in 2019, they presented research on BPA exposure's effects on circadian rhythms in mice during pregnancy. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

There are good days and bad days. For the endocrinologist, that bad day can happen when a grant application or journal submission is rejected or following a misstep with a patient or in the lab. In this episode, Aaron and guest host Cecilia Low Wang, MD, from the University of Colorado School of Medicine, talk about how young researchers and trainees can understand, learn from, and bounce back from rejection and other challenges when building a career in clinical practice or scientific research. Our guests are Joy Wu, MD, PhD, from Stanford University and Rob Fowkes, PhD, from the Royal Veterinary College at the University of London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

The Endocrine Society made news recently by launching a new, online-only, open-access journal called JCEM Case Reports, which is dedicated to clinical cases in endocrinology. What can we learn from case studies, and what does this journal have to offer? To answer those questions, host Aaron Lohr talks with JCEM Case Reports Editor-in-Chief William F. Young Jr., MD, the Tyson Family Endocrinology Clinical Professor and professor of medicine in the Mayo Clinic College of Medicine at Mayo Clinic in Rochester, Minn. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We interview Charles Sklar, from Memorial Sloan-Kettering Cancer Center, about the latest Endocrine Society clinical practice guideline. Dr. Sklar talks about the need to screen for endocrine disorders in long-term survivors of childhood cancer. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr went to Chicago in June to interview researchers presenting at the Endocrine Society’s annual meeting, ENDO 2023. Here he talks with Julie Hens, PhD, from Yale University about her team’s research, titled “Protective Effects of Lactation on Maternal Metabolism.” After that interview, listen to a sneak peek of our other, members-only podcast, Endocrine Feedback Loop, an episode from November 2022 about changes in glucose throughout the menstrual cycle in type 1 diabetes. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

For our 50th episode since launching in 2018, host Aaron Lohr takes a look at drone and robotic technology being used for medicine delivery and patient education. He speaks with Derek O’Keeffe, MD, PhD, of the National University of Ireland, Galway, who has been at the forefront of this development in patient care. Dr. O’Keeffe will present on Tuesday, November 9, at the Endocrine Society's upcoming half-day-long, educational event, “Insulin 2121: The Next 100 Years of Discoveries,” which you can register for at https://www.endocrine.org/insulin100 . This episode is sponsored by an unrestricted, educational grant from Lilly USA LLC. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We continue our special Women in Endocrinology series. Caitlin talks with Rebecca Simmons, MD, from the Children’s Hospital of Philadelphia, about her 2018 article in Endocrinology about islet dysfunction in intrauterine growth restriction. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron welcomes back Maria Fleseriu, MD, from Oregon Health and Science University, this time to talk about the latest in acromegaly research and treatment. He also speaks with Marvin Avila, an acromegaly patient living in the Washington, DC, metro area. Endocrine Society members, for a chance to win a pituitary pin, please complete a survey at https://education.endocrine.org/acromegalypodcast (login required). This episode is supported by Pfizer through an unrestricted, educational grant. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk about the sometimes conflicting perspectives in the treatment of menopausal symptoms with Cynthia Stuenkel, M.D., clinical professor of medicine at the University of California, San Diego, School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In recent years, much attention has been paid to the amount of Bisphenol A, or BPA, an endocrine-disrupting chemical, found in plastic products. But are the standards we have in place enough? Host Aaron Lohr talks with Heather Patisaul, PhD, of North Carolina State University. An Endocrine Society member, Dr. Patisaul is an expert on BPA whose research contributed to findings from a coalition that the Society participated in. This coalition of physicians, scientists, and public health and environmental organizations has petitioned the U.S. Food and Drug Administration to set stricter BPA limits in plastic food containers, among other products. This followed recent, stricter changes in European Union standards for BPA exposure. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast. This episode is sponsored by an unrestricted, educational grant from Novo Nordisk, Abbott Diabetes Care, and Medtronic.

Caitlin and Aaron talk with Kyle McNerney, MD, from Washington University in St. Louis School of Medicine. At ENDO 2019, Dr. McNerney presented a study to determine the connection between vitamin D deficiency in pregnancy and insulin resistance in children. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In another dispatch from ENDO 2023, host Aaron Lohr talks with Max Peterson, MD, PhD, from Washington University in St. Louis, about his team’s research presented at the meeting. Their presentation was titled, “Cellular Insights Into Metabolically Healthy and Unhealthy Obesity.” For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk with Ann E. Kearns, associate professor of medicine at the Mayo Clinic, about the questions endocrinologists are asked by their patients about osteoporosis. Dr. Kearns led a discussion about osteoporosis treatment and care in September at the Endocrine Society's Clinical Endocrinology Update in Miami. We spoke with her there. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. Browse to https://bit.ly/3uEqWto for more information and the certification course. This activity is supported by an educational grant from Lilly. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Aaron talks about treating Cushing's disease with Maria Fleseriu, MD, professor of medicine and neurological surgery at Oregon Health and Science University. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

The pandemic has changed the world of medical and science conferences, including the Endocrine Society's annual meeting, ENDO 2021, which will be an all-virtual event. Host Aaron Lohr talks with Felix Beuschlein, a professor at University Hospital Zurich and chair of the Society's annual meeting steering committee, about what to expect. ENDO 2021 will be held on March 20-23. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks some more with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about continuous glucose monitoring, training for caregivers and nurses, and telehealth. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Caitlin and Aaron talk with Dr. Anders Carlson, medical director of the International Diabetes Center in Minneapolis, about his research on hypoglycemia in older adults with type 1 diabetes. Dr. Carlson presented this research at the Endocrine Society’s 2019 annual meeting in New Orleans. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr talks about hypoglycemia with Elizabeth Seaquist, MD, from the University of Minnesota, and Cecilia Low Wang, MD, from the University of Colorado Hospital. Drs. Seaquist and Low Wang are the faculty of the ENDO Online 2020 session titled “Severe Hypoglycemia: The Frequently Forgotten Threat.” Once you have listened to the episode, let us know what you think about it by taking a survey, the link to which you can find on our website, https://www.endocrine.org/podcast (click on the episode link). Fill out the survey, and we will send you an insulin pin. This podcast is supported by an unrestricted, educational grant from Lilly.

Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lindsey Treviño, PhD, assistant professor at City of Hope National Medical Center. They talk not just about the effects of parabens as an EDC, but also about racial and ethnic disparities in risk and mortality, as well as research, and how Dr. Treviño and colleagues address these disparities. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of growth hormone deficiency in pediatric and adult patients with Dr. Mark E. Molitch, MD, Professor Emeritus of Medicine, Northwestern University Feinberg School of Medicine. In addition, Dr. Molitch gives listeners a four-question quiz at the end. Remember to pause in between the question and answer! This episode is certified for up to 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. This episode is made possible by an unrestricted, educational grant from Novo Nordisk. For helpful links, including to the AMA PRA exam, or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD, PhD, chairman of internal medicine at Charles R. Drew University of Medicine & Science and professor of medicine at University of California, Los Angeles. Dr. Friedman and colleagues’ oral presentation at ENDO 2022 is titled, “Fructose Consumption in Nonalcoholic Fatty Liver Disease in U.S. Adult Population of NHANES 17-18” (NHANES being a national health and nutrition examination survey). For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We look at sugars and appetite with Kathleen Page, MD, associate professor of medicine at the University of Southern California Keck School of Medicine. Dr. Page is the corresponding author of a new article published in The Journal of Clinical Endocrinology and Metabolism, “Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron catches up with Anuja Dokras MD, PhD, a physician at the Hospital of the University of Pennsylvania and director of the Penn Polycystic Ovary Syndrome Center, about her presentation at ENDO 2019 on anxiety, depression, and quality of life between white and black women with polycystic ovary syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.” What exactly is hypercalcemia of malignancy? What are its symptoms? How is it treated? And what do the guidelines recommend? To help answer these questions, host Aaron Lohr talks with Ghada El-Hajj Fuleihan, MD, MPH, professor of medicine at the American University in Beirut in Lebanon. She is the chair of the Society working group that developed this guideline. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes.”For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications? How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine Society's annual meeting. The abstract is titled “Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We celebrate women in endocrinology by launching this podcast series, talking with authors of 12 influential, high-impact research papers representing the spectrum of basic through clinical research, geographical diversity and career stage, published in Endocrine Society journals since 2017. Here we speak with Stina Rikke Jensen, PhD, a researcher at Novozymes in Denmark. Her 2017 Endocrinology paper, on biological roles of insulin and its receptor in murine intestinal growth and function, is part of a special thematic collection of these 12 influential papers. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron talks about thyroid and pregnancy with Elizabeth Pearce, professor of medicine at Boston University Medical Center and president of the American Thyroid Association. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Caitlin talks about the European Union’s recent resolution on endocrine-disrupting chemicals. She is joined by Rémy Slama, PhD, an environmental epidemiologist and senior investigator at INSERM, France’s National Institute of Health and Medical Research, and Barbara Demeneix, PhD, professor in the Comparative Physiology Laboratory within the Natural History Museum in Paris. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Alberto Ferlin, a professor of endocrinology at the University of Brescia, Italy, about his cohort findings connecting semen quality, reproductive function, and conditions in men such as hypogonadism, high body-mass index, and metabolic syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Getting published can be a challenging journey. In this episode, Caitlin and Aaron talk with Andrea Gore, Ph.D., from the University of Texas at Austin. Dr. Gore has published more than 150 articles and is a past Editor-in-Chief of the journal Endocrinology. Here she talks about what makes for a well-written scientific paper and about the peer review process: what to expect and how to understand the feedback from editors. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk about insulin affordability with Alvin Powers, MD, from Vanderbilt University and the Endocrine Society's chief professional and clinical affairs officer, Rob Lash, MD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive Symptoms in Women with Recent GDM.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral session during the annual meeting. The abstract is titled “Epidemic of Subclinical Ovulatory Disturbances During SARS-COV2 Pandemic—an Experiment of Nature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk with Stephanie Page, a professor of medicine at the University of Washington, about research on what she calls a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We begin the first in a four-part micro-series on endocrine in the time of COVID. Here Aaron talks with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about what we know right now about the effects of COVID-19 on the patient with diabetes. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about obesity, infertility, and a lifestyle intervention program, Fit for Fertility, presented during the Endocrine Society's annual meeting ENDO 2021 by researchers from the University of Sherbrooke in Canada. Here he speaks with the first author of the presentation, Matea Belan, PhD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s what we’re here to talk about today, as we look at the new scientific statement from the Endocrine Society titled, “Hormones and Aging: An Endocrine Society Scientific Statement.” Host Aaron Lohr talks with one of the statement’s authors, Anne Cappola, MD, a professor of medicine at the University of Pennsylvania and founding director of Penn Medical Communication Research Institute. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We continue in our four-part micro-series on endocrine in the time of COVID. Here Aaron talks about the health disparities we see in the pandemic, especially those affecting African-American patients, with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special interest group with the Endocrine Society, and she is a host of the podcast “Checkpoint NOW.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr talks about vitamin D insufficiency and COVID-19 with Laurel Mohrmann, MD, and Sweta Chekuri, MD, both from Montefiore Medical Center in the Bronx. Drs. Mohrmann and Chekuri participated on a team that presented in March on vitamin D insufficiency at ENDO 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk with Kristy Brown, assistant professor of biochemistry and medicine, and Priya Bhardwaj, a PhD candidate, both at Weill Cornell Medicine, about their research correlating obesity with DNA damage in the breast epithelium of BRCA mutation carriers, and investigating potential connections with adipose inflammation and elevated aromatase expression. They presented their research at the Endocrine Society's annual meeting in Chicago. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

The Endocrine Society’s chief professional and clinical affairs officer, Robert Lash, MD, talks with Griffin Rodgers, MD, director of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and William Cefalu, MD, director of NIDDK’s Division of Diabetes, Endocrinology and Metabolic Disease. They talk about the institute’s mission, the months since Dr. Cefalu took over the division, and their interactions with professional organizations like the Endocrine Society. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Today we celebrate 100 years since the discovery of insulin. We talk with Elizabeth A. Stephens, MD, an endocrinologist with the Providence Medical Group in Portland, Ore., about the importance of this landmark discovery, how it shaped our understanding and treatment of diabetes, and how it sets the stage for the exciting breakthroughs of tomorrow. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we speak with Angela Magdaleno, from the Lehigh Valley Health Network, about preconception counseling for women with diabetes. Dr. Magdaleno presented findings of a patient review and a survey of providers at the Endocrine Society’s annual meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In another interview from ENDO 2023, host Aaron Lohr talks with Silvana Duran Ortiz, Ph.D., a postdoctoral research fellow at Ohio University, about her team’s research presented at the meeting. Their presentation was titled, “Disruption of GHR in ‘Middle Aged’ Mice Enhances Insulin Sensitivity and Extends Male Lifespan.” For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Host Aaron Lohr talks with two researchers at ENDO 2023, Kyle Horlen, DVM, and Joshua Myers, both from Rani Therapeutics, about two presentations they made about an oral treatment of teriparatide for the treatment of osteoporosis. The two presentations are titled, “Pharmacokinetics (PK) and Pharmacodynamics (PD) of the Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered via an Orally Administered Robotic Pill (RT-102),” and “An Orally Administered Robotic Pill (RP) Reliably And Safely Delivers the Human Parathyroid Hormone Analog hPTH(1-34) (Teriparatide) With High Bioavailability in Healthy Human Volunteers: A Phase 1 Study.” For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We continue our special Women in Endocrinology series. Caitlin talks with Varykina Thackray, PhD, from the University of California, San Diego, about her 2018 article in JCEM about polycystic ovary syndrome and hyperandrogenism. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We hear from Christopher Mulla, MD, from the Joslin Diabetes Center in Boston, about his research about the closed loop glucagon pump as a strategy for post-bariatric hypoglycemia. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with James Findling from the Medical College of Wisconsin about the debate surrounding the symptoms that some see as indicative of adrenal fatigue and failure and others see as a false positive for a condition that, in fact, does not exist. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron talks about finding your path after your postdoc with W. Lee Kraus, PhD, from the University of Texas Southwestern Medical Center and Nicola Partridge, PhD, from New York University College of Dentistry. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about cardiovascular disease and type 2 diabetes with Jonathan Purnell, MD, from Oregon Health & Science University. Dr. Purnell chaired the Endocrine Society's recent educational series, “Current and Future State of Cardiovascular Disease in Type 2 Diabetes,” which is available through December 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Aaron speaks with Manasi Das, PhD, of the University of California San Diego. At ENDO 2019 in New Orleans, Dr. Das presented research on post-menopausal obesity, suggesting that time restricted feeding can delay breast cancer in a mouse model. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We look into promising findings from clinical trials regarding Burosumab, a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia. With us are Erik Imel, MD from the Indiana University School of Medicine and Suzanne Marie Jan De Beur, MD from Johns Hopkins University School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

R. Michael Tuttle, from Memorial Sloan Kettering and Weill Medical College, talks with Caitlin and Aaron about the upcoming ENDO 2019 and especially how first-time attendees and trainees can navigate the sometimes overwhelming experience. Also, Caitlin tells us about the upcoming Women in Endocrinology Thematic Collection. The Society is seeking nominations for this collection, which will be published in March in time for the meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

From ENDO 2023, host Aaron Lohr talks with Jayalakshmi Udayasankar, MD, from the Palo Alto Medical Foundation, about her team’s research presented at the meeting, titled, “Tingling Over Cheek: An Atypical Presentation of Invasive Fungal Sinusitis in an Ambulatory Patient With Type 2 Diabetes.” For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Today we look at a study from ENDO 2023 about COVID-19 exposure and weight gain in infants. Host Aaron Lohr talks with Mollie Ockene, a Clinical Research Coordinator at Massachusetts General Hospital and a co-author of the study, titled, “Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure.” Also, get a sneak peak at an episode of our members-only podcast Endocrine Feedback Loop which looks at a study in The Journal of Clinical Endocrinology & Metabolism about the glycemic gap in hospitalized patients with COVID. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects on fetal and neonatal endocrine puberty. Host Aaron Lohr talks with Mary Bunnell from the University of Illinois Urbana-Champaign, co-author of the study, titled, “Prenatal Phthalate Exposure Alters the Pattern of Fetal and Neonatal Endocrine Puberty in a Sex-specific Manner.” For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We know that illicit use of anabolic-androgenic steroids is dangerous, but cessation comes with its own challenges. Today we’re talking about a study presented at ENDO 2023 titled, “Self-Administration of Post-Cycle Therapy Is Associated With Increased Probability of Subsequent Normalisation of Reproductive Hormones Following Anabolic-Androgenic Steroid Cessation in Men.” Joining host Aaron Lohr to talk about it is one of the study authors, Channa Jayasena, MD, PhD, a specialist in reproductive endocrinology and a research team lead at Imperial College London. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type 1 diabetes fellows series. That program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but are there other, metabolic, and neuronendocrine effects from short sleep that we don’t know about. Host Aaron Lohr talks about this with Iris CM Pelsma, an academic researcher at Leiden University Medical Center in the Netherlands. She and her colleagues presented a study earlier this year, at ENDO 2023, titled, “Metabolic and Neuroendocrine Adaptability Following One Night of Partial Sleep Restriction in Dutch Males.” Show notes are available at https://www.endocrine.org/podcast/enp80-metabolic-and-neuroendocrine-effects-of-short-sleep — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The program covered a wealth of information, and host Aaron Lohr talks with Amy Rothberg, MD, DABOM, program chair and a clinical professor of internal medicine at the University of Michigan’s School of Public Health. If you weren’t able to attend the fellows program, we have a free series of on-demand lectures available online, and those are accredited. With thanks to Lilly USA LLC and Novo Nordisk for making both the obesity fellows program and this podcast episode possible through an unrestricted, educational grant. Show notes, including a link to the Endocrine Society Learning Center for earning ABIM points and AMA PRA Category 1 credits, are available at https://www.endocrine.org/podcast/enp81-obesity-fellows-program — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Aaron talks with Deborah Kurrasch, PhD, associate professor at the University of Calgary, and Dinu Nesan, PhD, postdoctoral fellow also at University of Calgary. At the Endocrine Society's annual meeting in 2019, they presented research on BPA exposure's effects on circadian rhythms in mice during pregnancy. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

The Endocrine Society made news recently by launching a new, online-only, open-access journal called JCEM Case Reports, which is dedicated to clinical cases in endocrinology. What can we learn from case studies, and what does this journal have to offer? To answer those questions, host Aaron Lohr talks with JCEM Case Reports Editor-in-Chief William F. Young Jr., MD, the Tyson Family Endocrinology Clinical Professor and professor of medicine in the Mayo Clinic College of Medicine at Mayo Clinic in Rochester, Minn. Show notes are available at https://www.endocrine.org/podcast/enp66-new-endocrine-society-journal-jcem-case-reports — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type 1 diabetes fellows series. That program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care. Show notes are available at https://www.endocrine.org/podcast/enp79-type-1-diabetes-update — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Aaron catches up with Anuja Dokras MD, PhD, a physician at the Hospital of the University of Pennsylvania and director of the Penn Polycystic Ovary Syndrome Center, about her presentation at ENDO 2019 on anxiety, depression, and quality of life between white and black women with polycystic ovary syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We explore type 1 diabetes, everything from diagnosis to treatment strategies, hypoglycemia, technology, and teleheath. Host Aaron Lohr talks with Irl Hirsch, MD, from the University of Washington, and Davida Kruger, NP, from the Henry Ford Health System. They co-chair the Endocrine Society's 8th Annual Endocrine Fellows Type 1 Diabetes Care and Management Program. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk about the sometimes conflicting perspectives in the treatment of menopausal symptoms with Cynthia Stuenkel, M.D., clinical professor of medicine at the University of California, San Diego, School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with James Findling from the Medical College of Wisconsin about the debate surrounding the symptoms that some see as indicative of adrenal fatigue and failure and others see as a false positive for a condition that, in fact, does not exist. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We know that illicit use of anabolic-androgenic steroids is dangerous, but cessation comes with its own challenges. Today we’re talking about a study presented at ENDO 2023 titled, “Self-Administration of Post-Cycle Therapy Is Associated With Increased Probability of Subsequent Normalisation of Reproductive Hormones Following Anabolic-Androgenic Steroid Cessation in Men.” Joining host Aaron Lohr to talk about it is one of the study authors, Channa Jayasena, MD, PhD, a specialist in reproductive endocrinology and a research team lead at Imperial College London. Show notes are available at https://www.endocrine.org/podcast/enp78-post-cycle-therapy-following-anabolic-androgenic-steroid-cessation — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. Show notes are available at https://www.endocrine.org/podcast/enp65-type-1-diabetes-and-challenges-across-the-lifespan — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In another dispatch from ENDO 2023, host Aaron Lohr talks with Max Petersen, MD, PhD, from Washington University in St. Louis, about his team’s research presented at the meeting. Their presentation was titled, “Cellular Insights Into Metabolically Healthy and Unhealthy Obesity.” Show notes are available at https://www.endocrine.org/podcast/enp74-healthy-and-unhealthy-obesity — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

The pandemic has changed the world of medical and science conferences, including the Endocrine Society's annual meeting, ENDO 2021, which will be an all-virtual event. Host Aaron Lohr talks with Felix Beuschlein, a professor at University Hospital Zurich and chair of the Society's annual meeting steering committee, about what to expect. ENDO 2021 will be held on March 20-23. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.” What exactly is hypercalcemia of malignancy? What are its symptoms? How is it treated? And what do the guidelines recommend? To help answer these questions, host Aaron Lohr talks with Ghada El-Hajj Fuleihan, MD, MPH, professor of medicine at the American University in Beirut in Lebanon. She is the chair of the Society working group that developed this guideline. Show notes are available at https://www.endocrine.org/podcast/enp68-hypercalcemia-of-malignancy — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We talk about insulin affordability with Alvin Powers, MD, from Vanderbilt University and the Endocrine Society's chief professional and clinical affairs officer, Rob Lash, MD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron talks about finding your path after your postdoc with W. Lee Kraus, PhD, from the University of Texas Southwestern Medical Center and Nicola Partridge, PhD, from New York University College of Dentistry. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. Show notes are available at https://www.endocrine.org/podcast/enp69-biosimilar-insulin — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of growth hormone deficiency in pediatric and adult patients with Dr. Mark E. Molitch, MD, Professor Emeritus of Medicine, Northwestern University Feinberg School of Medicine. In addition, Dr. Molitch gives listeners a four-question quiz at the end. Remember to pause in between the question and answer! This episode is certified for up to 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. This episode is made possible by an unrestricted, educational grant from Novo Nordisk. Show notes are available at https://www.endocrine.org/podcast/enp67-growth-hormone-deficiency — for helpful links, including to the AMA PRA exam, or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Host Aaron Lohr talks with two researchers at ENDO 2023, Kyle Horlen, DVM, and Joshua Myers, both from Rani Therapeutics, about two presentations they made about an oral treatment of teriparatide for the treatment of osteoporosis. The two presentations are titled, “Pharmacokinetics (PK) and Pharmacodynamics (PD) of the Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered via an Orally Administered Robotic Pill (RT-102),” and “An Orally Administered Robotic Pill (RP) Reliably And Safely Delivers the Human Parathyroid Hormone Analog hPTH(1-34) (Teriparatide) With High Bioavailability in Healthy Human Volunteers: A Phase 1 Study.” Show notes are available at https://www.endocrine.org/podcast/enp73-a-robotic-teriparatide-pill-to-treat-osteoporosis — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Getting published can be a challenging journey. In this episode, Caitlin and Aaron talk with Andrea Gore, Ph.D., from the University of Texas at Austin. Dr. Gore has published more than 150 articles and is a past Editor-in-Chief of the journal Endocrinology. Here she talks about what makes for a well-written scientific paper and about the peer review process: what to expect and how to understand the feedback from editors. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Caitlin and Aaron talk with Kyle McNerney, MD, from Washington University in St. Louis School of Medicine. At ENDO 2019, Dr. McNerney presented a study to determine the connection between vitamin D deficiency in pregnancy and insulin resistance in children. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In recent years, much attention has been paid to the amount of Bisphenol A, or BPA, an endocrine-disrupting chemical, found in plastic products. But are the standards we have in place enough? Host Aaron Lohr talks with Heather Patisaul, PhD, of North Carolina State University. An Endocrine Society member, Dr. Patisaul is an expert on BPA whose research contributed to findings from a coalition that the Society participated in. This coalition of physicians, scientists, and public health and environmental organizations has petitioned the U.S. Food and Drug Administration to set stricter BPA limits in plastic food containers, among other products. This followed recent, stricter changes in European Union standards for BPA exposure. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s what we’re here to talk about today, as we look at the new scientific statement from the Endocrine Society titled, “Hormones and Aging: An Endocrine Society Scientific Statement.” Host Aaron Lohr talks with one of the statement’s authors, Anne Cappola, MD, a professor of medicine at the University of Pennsylvania and founding director of Penn Medical Communication Research Institute. Show notes are available at https://www.endocrine.org/podcast/enp70-hormones-and-aging — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Caitlin talks about the European Union’s recent resolution on endocrine-disrupting chemicals. She is joined by Rémy Slama, PhD, an environmental epidemiologist and senior investigator at INSERM, France’s National Institute of Health and Medical Research, and Barbara Demeneix, PhD, professor in the Comparative Physiology Laboratory within the Natural History Museum in Paris. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Today we look at a study from ENDO 2023 about COVID-19 exposure and weight gain in infants. Host Aaron Lohr talks with Mollie Ockene, a Clinical Research Coordinator at Massachusetts General Hospital and a co-author of the study, titled, “Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure.” Also, get a sneak peak at an episode of our members-only podcast Endocrine Feedback Loop which looks at a study in The Journal of Clinical Endocrinology & Metabolism about the glycemic gap in hospitalized patients with COVID. Show notes are available at https://www.endocrine.org/podcast/enp76-infants-and-in-utero-exposure-to-covid — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In this episode, we learn about endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS), which break down so slowly that they have been called “forever chemicals.” Where can PFAS be found? What exactly is their effect on human health? What are manufacturers doing to limit exposure, and is it enough? Host Aaron Lohr talks with Benson T. Akingbemi, PhD, professor of anatomy and developmental biology at Auburn University. Dr. Akingbemi and colleagues recently published an article on PFAS in the journal Endocrinology titled, “Legacy and Emerging Perfluoroalkyl and Polyfluoroalkyl Substances Regulate Steroidogenesis in the Male Gonad.” Show notes are available at https://www.endocrine.org/podcast/enp82-pfas — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We interview Charles Sklar, from Memorial Sloan-Kettering Cancer Center, about the latest Endocrine Society clinical practice guideline. Dr. Sklar talks about the need to screen for endocrine disorders in long-term survivors of childhood cancer. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” Show notes are available at https://www.endocrine.org/podcast/enp63-vosoritide-and-children-with-genetic-short-stature — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We continue in our four-part micro-series on endocrine in the time of COVID. Here Aaron talks about the health disparities we see in the pandemic, especially those affecting African-American patients, with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Stephanie Page, a professor of medicine at the University of Washington, about research on what she calls a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Ann E. Kearns, associate professor of medicine at the Mayo Clinic, about the questions endocrinologists are asked by their patients about osteoporosis. Dr. Kearns led a discussion about osteoporosis treatment and care in September at the Endocrine Society's Clinical Endocrinology Update in Miami. We spoke with her there. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr went to Chicago in June to interview researchers presenting at the Endocrine Society’s annual meeting, ENDO 2023. Here he talks with Julie Hens, PhD, from Yale University about her team’s research, titled “Protective Effects of Lactation on Maternal Metabolism.” After that interview, listen to a sneak peek of our other, members-only podcast, Endocrine Feedback Loop, an episode from November 2022 about changes in glucose throughout the menstrual cycle in type 1 diabetes. Show notes are available at https://www.endocrine.org/podcast/enp71-lactation-and-maternal-metabolism — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Host Aaron Lohr talks about obesity, infertility, and a lifestyle intervention program, Fit for Fertility, presented during the Endocrine Society's annual meeting ENDO 2021 by researchers from the University of Sherbrooke in Canada. Here he speaks with the first author of the presentation, Matea Belan, PhD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” Show notes are available at https://www.endocrine.org/podcast/enp64-more-testing-needed-for-men-with-hypogonadism — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

A new study in The Journal of Clinical Endocrinology & Metabolism shows the relationship between abnormal sodium levels and greater risk of respiratory failure and death in patients with COVID-19. Host Aaron Lohr speaks with two of the authors, Ploutarchos Tzoulis, MD, PhD, from University College London Medical School and Julian Waung, PhD, from the Whittington Health NHS Trust in London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Caitlin and Aaron talk with Dr. Anders Carlson, medical director of the International Diabetes Center in Minneapolis, about his research on hypoglycemia in older adults with type 1 diabetes. Dr. Carlson presented this research at the Endocrine Society’s 2019 annual meeting in New Orleans. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about vitamin D insufficiency and COVID-19 with Laurel Mohrmann, MD, and Sweta Chekuri, MD, both from Montefiore Medical Center in the Bronx. Drs. Mohrmann and Chekuri participated on a team that presented in March on vitamin D insufficiency at ENDO 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk about nuclear receptor biology with Laurel Coons, first author of an Endocrinology article on hormone-mediated enhancer activation. The Endocrine Society is a sponsor of the upcoming Great Lakes Nuclear Receptor Conference in Minneapolis and is excited to share this nuclear receptor focused interview with you. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk about diabetes and cancer with Anupam Kotwal, endocrinology fellow at the Mayo Clinic. His research shows the potential for autoimmune diabetes outcomes from novel anti-cancer agents. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

For our 50th episode since launching in 2018, host Aaron Lohr takes a look at drone and robotic technology being used for medicine delivery and patient education. He speaks with Derek O’Keeffe, MD, PhD, of the National University of Ireland, Galway, who has been at the forefront of this development in patient care. Dr. O’Keeffe will present on Tuesday, November 9, at the Endocrine Society's upcoming half-day-long, educational event, “Insulin 2121: The Next 100 Years of Discoveries,” which you can register for at https://www.endocrine.org/insulin100 . This episode is sponsored by an unrestricted, educational grant from Lilly USA LLC. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

R. Michael Tuttle, from Memorial Sloan Kettering and Weill Medical College, talks with Caitlin and Aaron about the upcoming ENDO 2019 and especially how first-time attendees and trainees can navigate the sometimes overwhelming experience. Also, Caitlin tells us about the upcoming Women in Endocrinology Thematic Collection. The Society is seeking nominations for this collection, which will be published in March in time for the meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Aaron welcomes back Maria Fleseriu, MD, from Oregon Health and Science University, this time to talk about the latest in acromegaly research and treatment. He also speaks with Marvin Avila, an acromegaly patient living in the Washington, DC, metro area. Endocrine Society members, for a chance to win a pituitary pin, please complete a survey at https://education.endocrine.org/acromegalypodcast (login required). This episode is supported by Pfizer through an unrestricted, educational grant. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks some more with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about continuous glucose monitoring, training for caregivers and nurses, and telehealth. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications? How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine Society's annual meeting. The abstract is titled “Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. Browse to https://bit.ly/3uEqWto for more information and the certification course. This activity is supported by an educational grant from Lilly. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Aaron talks about thyroid and pregnancy with Elizabeth Pearce, professor of medicine at Boston University Medical Center and president of the American Thyroid Association. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

From ENDO 2023, host Aaron Lohr talks with Jayalakshmi Udayasankar, MD, from the Palo Alto Medical Foundation, about her team’s research presented at the meeting, titled, “Tingling Over Cheek: An Atypical Presentation of Invasive Fungal Sinusitis in an Ambulatory Patient With Type 2 Diabetes.” Show notes are available at https://www.endocrine.org/podcast/enp75-a-case-study-on-fungal-sinusitis-in-t2d — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Today we celebrate 100 years since the discovery of insulin. We talk with Elizabeth A. Stephens, MD, an endocrinologist with the Providence Medical Group in Portland, Ore., about the importance of this landmark discovery, how it shaped our understanding and treatment of diabetes, and how it sets the stage for the exciting breakthroughs of tomorrow. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD, PhD, chairman of internal medicine at Charles R. Drew University of Medicine & Science and professor of medicine at University of California, Los Angeles. Dr. Friedman and colleagues’ oral presentation at ENDO 2022 is titled, “Fructose Consumption in Nonalcoholic Fatty Liver Disease in U.S. Adult Population of NHANES 17-18” (NHANES being a national health and nutrition examination survey). For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We look into promising findings from clinical trials regarding Burosumab, a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia. With us are Erik Imel, MD from the Indiana University School of Medicine and Suzanne Marie Jan De Beur, MD from Johns Hopkins University School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about thyroiditis and COVID-19 with Ilaria Muller, MD, PhD, from the University of Milan. Dr. Muller presented her research in March at ENDO 2021: “Early Follow-up of Atypical Thyroiditis Induced by SARS-CoV-2.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Caitlin talks with author and researcher Nayara Aquino, PhD, from the Federal University of Minas Gerais, Brazil, about her research on neuroendocrine control of the female reproductive system. Her paper, published in Endocrinology in June 2017, was selected for the Endocrine Society’s Women in Endocrinology Thematic Issue. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron talks about treating Cushing's disease with Maria Fleseriu, MD, professor of medicine and neurological surgery at Oregon Health and Science University. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral session during the annual meeting. The abstract is titled “Epidemic of Subclinical Ovulatory Disturbances During SARS-COV2 Pandemic—an Experiment of Nature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We look at sugars and appetite with Kathleen Page, MD, associate professor of medicine at the University of Southern California Keck School of Medicine. Dr. Page is the corresponding author of a new article published in The Journal of Clinical Endocrinology and Metabolism, “Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We celebrate women in endocrinology by launching this podcast series, talking with authors of 12 influential, high-impact research papers representing the spectrum of basic through clinical research, geographical diversity and career stage, published in Endocrine Society journals since 2017. Here we speak with Stina Rikke Jensen, PhD, a researcher at Novozymes in Denmark. Her 2017 Endocrinology paper, on biological roles of insulin and its receptor in murine intestinal growth and function, is part of a special thematic collection of these 12 influential papers. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We continue our special Women in Endocrinology series. Caitlin talks with Varykina Thackray, PhD, from the University of California, San Diego, about her 2018 article in JCEM about polycystic ovary syndrome and hyperandrogenism. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Kristy Brown, assistant professor of biochemistry and medicine, and Priya Bhardwaj, a PhD candidate, both at Weill Cornell Medicine, about their research correlating obesity with DNA damage in the breast epithelium of BRCA mutation carriers, and investigating potential connections with adipose inflammation and elevated aromatase expression. They presented their research at the Endocrine Society's annual meeting in Chicago. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. Show notes are available at https://www.endocrine.org/podcast/enp61-islet-cell-transplantation-for-diabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks more with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. Dr. Joseph talks about disparities in research funding and the need for mentoring for young researchers, changes in policymaking that helps poor and BIPOC communities, and more engagement by endocrinologists both in the pandemic and in the treatment of all communities. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

There are good days and bad days. For the endocrinologist, that bad day can happen when a grant application or journal submission is rejected or following a misstep with a patient or in the lab. In this episode, Aaron and guest host Cecilia Low Wang, MD, from the University of Colorado School of Medicine, talk about how young researchers and trainees can understand, learn from, and bounce back from rejection and other challenges when building a career in clinical practice or scientific research. Our guests are Joy Wu, MD, PhD, from Stanford University and Rob Fowkes, PhD, from the Royal Veterinary College at the University of London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast. This episode is sponsored by an unrestricted, educational grant from Novo Nordisk, Abbott Diabetes Care, and Medtronic.

Host Aaron Lohr talks about hypoglycemia with Elizabeth Seaquist, MD, from the University of Minnesota, and Cecilia Low Wang, MD, from the University of Colorado Hospital. Drs. Seaquist and Low Wang are the faculty of the ENDO Online 2020 session titled “Severe Hypoglycemia: The Frequently Forgotten Threat.” Once you have listened to the episode, let us know what you think about it by taking a survey, the link to which you can find on our website, https://www.endocrine.org/podcast (click on the episode link). Fill out the survey, and we will send you an insulin pin. This podcast is supported by an unrestricted, educational grant from Lilly.

We continue our special Women in Endocrinology series. Caitlin talks with Rebecca Simmons, MD, from the Children’s Hospital of Philadelphia, about her 2018 article in Endocrinology about islet dysfunction in intrauterine growth restriction. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

The Endocrine Society’s chief professional and clinical affairs officer, Robert Lash, MD, talks with Griffin Rodgers, MD, director of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and William Cefalu, MD, director of NIDDK’s Division of Diabetes, Endocrinology and Metabolic Disease. They talk about the institute’s mission, the months since Dr. Cefalu took over the division, and their interactions with professional organizations like the Endocrine Society. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about cardiovascular disease and type 2 diabetes with Jonathan Purnell, MD, from Oregon Health & Science University. Dr. Purnell chaired the Endocrine Society's recent educational series, “Current and Future State of Cardiovascular Disease in Type 2 Diabetes,” which is available through December 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We begin the first in a four-part micro-series on endocrine in the time of COVID. Here Aaron talks with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about what we know right now about the effects of COVID-19 on the patient with diabetes. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we speak with Angela Magdaleno, from the Lehigh Valley Health Network, about preconception counseling for women with diabetes. Dr. Magdaleno presented findings of a patient review and a survey of providers at the Endocrine Society’s annual meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We hear from Christopher Mulla, MD, from the Joslin Diabetes Center in Boston, about his research about the closed loop glucagon pump as a strategy for post-bariatric hypoglycemia. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In another interview from ENDO 2023, host Aaron Lohr talks with Silvana Duran Ortiz, Ph.D., a postdoctoral research fellow at Ohio University, about her team’s research presented at the meeting. Their presentation was titled, “Disruption of GHR in ‘Middle Aged’ Mice Enhances Insulin Sensitivity and Extends Male Lifespan.” Show notes are available at https://www.endocrine.org/podcast/enp72-ghr-insulin-and-life-span — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

As part of Women’s Health Month, we speak with Jerilynn Prior, who talks about a new treatment approach to perimenopause: oral, micronized progesterone. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron speaks with Manasi Das, PhD, of the University of California San Diego. At ENDO 2019 in New Orleans, Dr. Das presented research on post-menopausal obesity, suggesting that time restricted feeding can delay breast cancer in a mouse model. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The program covered a wealth of information, and host Aaron Lohr talks with Amy Rothberg, MD, DABOM, program chair and a clinical professor of internal medicine at the University of Michigan’s School of Public Health. If you weren’t able to attend the fellows program, we have a free series of on-demand lectures available online, and those are accredited. With thanks to Lilly USA LLC and Novo Nordisk for making both the obesity fellows program and this podcast episode possible through an unrestricted, educational grant. Show notes, including a link to the Endocrine Society Learning Center for earning ABIM points and AMA PRA Category 1 credits, are available at https://www.endocrine.org/podcast/enp81-obesity-fellows-program — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive Symptoms in Women with Recent GDM.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects on fetal and neonatal endocrine puberty. Host Aaron Lohr talks with Mary Bunnell from the University of Illinois Urbana-Champaign, co-author of the study, titled, “Prenatal Phthalate Exposure Alters the Pattern of Fetal and Neonatal Endocrine Puberty in a Sex-specific Manner.” Show notes are available at https://www.endocrine.org/podcast/enp77-phthalates-and-endocrine-puberty — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special interest group with the Endocrine Society, and she is a host of the podcast “Checkpoint NOW.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes.”For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk with Alberto Ferlin, a professor of endocrinology at the University of Brescia, Italy, about his cohort findings connecting semen quality, reproductive function, and conditions in men such as hypogonadism, high body-mass index, and metabolic syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes.” Show notes are available at https://www.endocrine.org/podcast/enp60-cgm-and-prediabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lindsey Treviño, PhD, assistant professor at City of Hope National Medical Center. They talk not just about the effects of parabens as an EDC, but also about racial and ethnic disparities in risk and mortality, as well as research, and how Dr. Treviño and colleagues address these disparities. Show notes are available at https://www.endocrine.org/podcast/enp62-parabens-as-an-edc-and-addressing-disparities-in-risk-and-research — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

A year after we interviewed her at ENDO 2018, we talk again with Stephanie Page, MD, PhD, from University of Washington, about her continuing research on a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but are there other, metabolic, and neuronendocrine effects from short sleep that we don’t know about. Host Aaron Lohr talks about this with Iris CM Pelsma, an academic researcher at Leiden University Medical Center in the Netherlands. She and her colleagues presented a study earlier this year, at ENDO 2023, titled, “Metabolic and Neuroendocrine Adaptability Following One Night of Partial Sleep Restriction in Dutch Males.” Show notes are available at https://www.endocrine.org/podcast/enp80-metabolic-and-neuroendocrine-effects-of-short-sleep — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We talk about the sometimes conflicting perspectives in the treatment of menopausal symptoms with Cynthia Stuenkel, M.D., clinical professor of medicine at the University of California, San Diego, School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron talks about thyroid and pregnancy with Elizabeth Pearce, professor of medicine at Boston University Medical Center and president of the American Thyroid Association. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.” What exactly is hypercalcemia of malignancy? What are its symptoms? How is it treated? And what do the guidelines recommend? To help answer these questions, host Aaron Lohr talks with Ghada El-Hajj Fuleihan, MD, MPH, professor of medicine at the American University in Beirut in Lebanon. She is the chair of the Society working group that developed this guideline. Show notes are available at https://www.endocrine.org/podcast/enp68-hypercalcemia-of-malignancy — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. Browse to https://bit.ly/3uEqWto for more information and the certification course. This activity is supported by an educational grant from Lilly. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk about diabetes and cancer with Anupam Kotwal, endocrinology fellow at the Mayo Clinic. His research shows the potential for autoimmune diabetes outcomes from novel anti-cancer agents. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we speak with Angela Magdaleno, from the Lehigh Valley Health Network, about preconception counseling for women with diabetes. Dr. Magdaleno presented findings of a patient review and a survey of providers at the Endocrine Society’s annual meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. Show notes are available at https://www.endocrine.org/podcast/enp69-biosimilar-insulin — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Aaron speaks with Manasi Das, PhD, of the University of California San Diego. At ENDO 2019 in New Orleans, Dr. Das presented research on post-menopausal obesity, suggesting that time restricted feeding can delay breast cancer in a mouse model. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Getting published can be a challenging journey. In this episode, Caitlin and Aaron talk with Andrea Gore, Ph.D., from the University of Texas at Austin. Dr. Gore has published more than 150 articles and is a past Editor-in-Chief of the journal Endocrinology. Here she talks about what makes for a well-written scientific paper and about the peer review process: what to expect and how to understand the feedback from editors. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We continue in our four-part micro-series on endocrine in the time of COVID. Here Aaron talks about the health disparities we see in the pandemic, especially those affecting African-American patients, with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We begin the first in a four-part micro-series on endocrine in the time of COVID. Here Aaron talks with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about what we know right now about the effects of COVID-19 on the patient with diabetes. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

For our 50th episode since launching in 2018, host Aaron Lohr takes a look at drone and robotic technology being used for medicine delivery and patient education. He speaks with Derek O’Keeffe, MD, PhD, of the National University of Ireland, Galway, who has been at the forefront of this development in patient care. Dr. O’Keeffe will present on Tuesday, November 9, at the Endocrine Society's upcoming half-day-long, educational event, “Insulin 2121: The Next 100 Years of Discoveries,” which you can register for at https://www.endocrine.org/insulin100 . This episode is sponsored by an unrestricted, educational grant from Lilly USA LLC. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk about insulin affordability with Alvin Powers, MD, from Vanderbilt University and the Endocrine Society's chief professional and clinical affairs officer, Rob Lash, MD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks more with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. Dr. Joseph talks about disparities in research funding and the need for mentoring for young researchers, changes in policymaking that helps poor and BIPOC communities, and more engagement by endocrinologists both in the pandemic and in the treatment of all communities. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We hear from Christopher Mulla, MD, from the Joslin Diabetes Center in Boston, about his research about the closed loop glucagon pump as a strategy for post-bariatric hypoglycemia. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type 1 diabetes fellows series. That program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care. Show notes are available at https://www.endocrine.org/podcast/enp79-type-1-diabetes-update — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive Symptoms in Women with Recent GDM.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Caitlin and Aaron talk with Dr. Anders Carlson, medical director of the International Diabetes Center in Minneapolis, about his research on hypoglycemia in older adults with type 1 diabetes. Dr. Carlson presented this research at the Endocrine Society’s 2019 annual meeting in New Orleans. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about hypoglycemia with Elizabeth Seaquist, MD, from the University of Minnesota, and Cecilia Low Wang, MD, from the University of Colorado Hospital. Drs. Seaquist and Low Wang are the faculty of the ENDO Online 2020 session titled “Severe Hypoglycemia: The Frequently Forgotten Threat.” Once you have listened to the episode, let us know what you think about it by taking a survey, the link to which you can find on our website, https://www.endocrine.org/podcast (click on the episode link). Fill out the survey, and we will send you an insulin pin. This podcast is supported by an unrestricted, educational grant from Lilly.

There are good days and bad days. For the endocrinologist, that bad day can happen when a grant application or journal submission is rejected or following a misstep with a patient or in the lab. In this episode, Aaron and guest host Cecilia Low Wang, MD, from the University of Colorado School of Medicine, talk about how young researchers and trainees can understand, learn from, and bounce back from rejection and other challenges when building a career in clinical practice or scientific research. Our guests are Joy Wu, MD, PhD, from Stanford University and Rob Fowkes, PhD, from the Royal Veterinary College at the University of London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral session during the annual meeting. The abstract is titled “Epidemic of Subclinical Ovulatory Disturbances During SARS-COV2 Pandemic—an Experiment of Nature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, we learn about endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS), which break down so slowly that they have been called “forever chemicals.” Where can PFAS be found? What exactly is their effect on human health? What are manufacturers doing to limit exposure, and is it enough? Host Aaron Lohr talks with Benson T. Akingbemi, PhD, professor of anatomy and developmental biology at Auburn University. Dr. Akingbemi and colleagues recently published an article on PFAS in the journal Endocrinology titled, “Legacy and Emerging Perfluoroalkyl and Polyfluoroalkyl Substances Regulate Steroidogenesis in the Male Gonad.” Show notes are available at https://www.endocrine.org/podcast/enp82-pfas — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special interest group with the Endocrine Society, and she is a host of the podcast “Checkpoint NOW.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Caitlin and Aaron talk with Kyle McNerney, MD, from Washington University in St. Louis School of Medicine. At ENDO 2019, Dr. McNerney presented a study to determine the connection between vitamin D deficiency in pregnancy and insulin resistance in children. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

A year after we interviewed her at ENDO 2018, we talk again with Stephanie Page, MD, PhD, from University of Washington, about her continuing research on a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron talks about treating Cushing's disease with Maria Fleseriu, MD, professor of medicine and neurological surgery at Oregon Health and Science University. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes.”For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We look at sugars and appetite with Kathleen Page, MD, associate professor of medicine at the University of Southern California Keck School of Medicine. Dr. Page is the corresponding author of a new article published in The Journal of Clinical Endocrinology and Metabolism, “Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We look into promising findings from clinical trials regarding Burosumab, a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia. With us are Erik Imel, MD from the Indiana University School of Medicine and Suzanne Marie Jan De Beur, MD from Johns Hopkins University School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. Show notes are available at https://www.endocrine.org/podcast/enp61-islet-cell-transplantation-for-diabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In recent years, much attention has been paid to the amount of Bisphenol A, or BPA, an endocrine-disrupting chemical, found in plastic products. But are the standards we have in place enough? Host Aaron Lohr talks with Heather Patisaul, PhD, of North Carolina State University. An Endocrine Society member, Dr. Patisaul is an expert on BPA whose research contributed to findings from a coalition that the Society participated in. This coalition of physicians, scientists, and public health and environmental organizations has petitioned the U.S. Food and Drug Administration to set stricter BPA limits in plastic food containers, among other products. This followed recent, stricter changes in European Union standards for BPA exposure. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We talk about nuclear receptor biology with Laurel Coons, first author of an Endocrinology article on hormone-mediated enhancer activation. The Endocrine Society is a sponsor of the upcoming Great Lakes Nuclear Receptor Conference in Minneapolis and is excited to share this nuclear receptor focused interview with you. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” Show notes are available at https://www.endocrine.org/podcast/enp64-more-testing-needed-for-men-with-hypogonadism — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We interview Charles Sklar, from Memorial Sloan-Kettering Cancer Center, about the latest Endocrine Society clinical practice guideline. Dr. Sklar talks about the need to screen for endocrine disorders in long-term survivors of childhood cancer. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We continue our special Women in Endocrinology series. Caitlin talks with Rebecca Simmons, MD, from the Children’s Hospital of Philadelphia, about her 2018 article in Endocrinology about islet dysfunction in intrauterine growth restriction. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Kristy Brown, assistant professor of biochemistry and medicine, and Priya Bhardwaj, a PhD candidate, both at Weill Cornell Medicine, about their research correlating obesity with DNA damage in the breast epithelium of BRCA mutation carriers, and investigating potential connections with adipose inflammation and elevated aromatase expression. They presented their research at the Endocrine Society's annual meeting in Chicago. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Ann E. Kearns, associate professor of medicine at the Mayo Clinic, about the questions endocrinologists are asked by their patients about osteoporosis. Dr. Kearns led a discussion about osteoporosis treatment and care in September at the Endocrine Society's Clinical Endocrinology Update in Miami. We spoke with her there. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr went to Chicago in June to interview researchers presenting at the Endocrine Society’s annual meeting, ENDO 2023. Here he talks with Julie Hens, PhD, from Yale University about her team’s research, titled “Protective Effects of Lactation on Maternal Metabolism.” After that interview, listen to a sneak peek of our other, members-only podcast, Endocrine Feedback Loop, an episode from November 2022 about changes in glucose throughout the menstrual cycle in type 1 diabetes. Show notes are available at https://www.endocrine.org/podcast/enp71-lactation-and-maternal-metabolism — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We talk with Alberto Ferlin, a professor of endocrinology at the University of Brescia, Italy, about his cohort findings connecting semen quality, reproductive function, and conditions in men such as hypogonadism, high body-mass index, and metabolic syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron catches up with Anuja Dokras MD, PhD, a physician at the Hospital of the University of Pennsylvania and director of the Penn Polycystic Ovary Syndrome Center, about her presentation at ENDO 2019 on anxiety, depression, and quality of life between white and black women with polycystic ovary syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lindsey Treviño, PhD, assistant professor at City of Hope National Medical Center. They talk not just about the effects of parabens as an EDC, but also about racial and ethnic disparities in risk and mortality, as well as research, and how Dr. Treviño and colleagues address these disparities. Show notes are available at https://www.endocrine.org/podcast/enp62-parabens-as-an-edc-and-addressing-disparities-in-risk-and-research — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Aaron talks about finding your path after your postdoc with W. Lee Kraus, PhD, from the University of Texas Southwestern Medical Center and Nicola Partridge, PhD, from New York University College of Dentistry. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes.” Show notes are available at https://www.endocrine.org/podcast/enp60-cgm-and-prediabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr talks about obesity, infertility, and a lifestyle intervention program, Fit for Fertility, presented during the Endocrine Society's annual meeting ENDO 2021 by researchers from the University of Sherbrooke in Canada. Here he speaks with the first author of the presentation, Matea Belan, PhD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks some more with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about continuous glucose monitoring, training for caregivers and nurses, and telehealth. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD, PhD, chairman of internal medicine at Charles R. Drew University of Medicine & Science and professor of medicine at University of California, Los Angeles. Dr. Friedman and colleagues’ oral presentation at ENDO 2022 is titled, “Fructose Consumption in Nonalcoholic Fatty Liver Disease in U.S. Adult Population of NHANES 17-18” (NHANES being a national health and nutrition examination survey). For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

The Endocrine Society made news recently by launching a new, online-only, open-access journal called JCEM Case Reports, which is dedicated to clinical cases in endocrinology. What can we learn from case studies, and what does this journal have to offer? To answer those questions, host Aaron Lohr talks with JCEM Case Reports Editor-in-Chief William F. Young Jr., MD, the Tyson Family Endocrinology Clinical Professor and professor of medicine in the Mayo Clinic College of Medicine at Mayo Clinic in Rochester, Minn. Show notes are available at https://www.endocrine.org/podcast/enp66-new-endocrine-society-journal-jcem-case-reports — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s what we’re here to talk about today, as we look at the new scientific statement from the Endocrine Society titled, “Hormones and Aging: An Endocrine Society Scientific Statement.” Host Aaron Lohr talks with one of the statement’s authors, Anne Cappola, MD, a professor of medicine at the University of Pennsylvania and founding director of Penn Medical Communication Research Institute. Show notes are available at https://www.endocrine.org/podcast/enp70-hormones-and-aging — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In another interview from ENDO 2023, host Aaron Lohr talks with Silvana Duran Ortiz, Ph.D., a postdoctoral research fellow at Ohio University, about her team’s research presented at the meeting. Their presentation was titled, “Disruption of GHR in ‘Middle Aged’ Mice Enhances Insulin Sensitivity and Extends Male Lifespan.” Show notes are available at https://www.endocrine.org/podcast/enp72-ghr-insulin-and-life-span — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast. This episode is sponsored by an unrestricted, educational grant from Novo Nordisk, Abbott Diabetes Care, and Medtronic.

In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of growth hormone deficiency in pediatric and adult patients with Dr. Mark E. Molitch, MD, Professor Emeritus of Medicine, Northwestern University Feinberg School of Medicine. In addition, Dr. Molitch gives listeners a four-question quiz at the end. Remember to pause in between the question and answer! This episode is certified for up to 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. This episode is made possible by an unrestricted, educational grant from Novo Nordisk. Show notes are available at https://www.endocrine.org/podcast/enp67-growth-hormone-deficiency — for helpful links, including to the AMA PRA exam, or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but are there other, metabolic, and neuronendocrine effects from short sleep that we don’t know about. Host Aaron Lohr talks about this with Iris CM Pelsma, an academic researcher at Leiden University Medical Center in the Netherlands. She and her colleagues presented a study earlier this year, at ENDO 2023, titled, “Metabolic and Neuroendocrine Adaptability Following One Night of Partial Sleep Restriction in Dutch Males.” Show notes are available at https://www.endocrine.org/podcast/enp80-metabolic-and-neuroendocrine-effects-of-short-sleep — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

R. Michael Tuttle, from Memorial Sloan Kettering and Weill Medical College, talks with Caitlin and Aaron about the upcoming ENDO 2019 and especially how first-time attendees and trainees can navigate the sometimes overwhelming experience. Also, Caitlin tells us about the upcoming Women in Endocrinology Thematic Collection. The Society is seeking nominations for this collection, which will be published in March in time for the meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We know that illicit use of anabolic-androgenic steroids is dangerous, but cessation comes with its own challenges. Today we’re talking about a study presented at ENDO 2023 titled, “Self-Administration of Post-Cycle Therapy Is Associated With Increased Probability of Subsequent Normalisation of Reproductive Hormones Following Anabolic-Androgenic Steroid Cessation in Men.” Joining host Aaron Lohr to talk about it is one of the study authors, Channa Jayasena, MD, PhD, a specialist in reproductive endocrinology and a research team lead at Imperial College London. Show notes are available at https://www.endocrine.org/podcast/enp78-post-cycle-therapy-following-anabolic-androgenic-steroid-cessation — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

The Endocrine Society’s chief professional and clinical affairs officer, Robert Lash, MD, talks with Griffin Rodgers, MD, director of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and William Cefalu, MD, director of NIDDK’s Division of Diabetes, Endocrinology and Metabolic Disease. They talk about the institute’s mission, the months since Dr. Cefalu took over the division, and their interactions with professional organizations like the Endocrine Society. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications? How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine Society's annual meeting. The abstract is titled “Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Today we look at a study from ENDO 2023 about COVID-19 exposure and weight gain in infants. Host Aaron Lohr talks with Mollie Ockene, a Clinical Research Coordinator at Massachusetts General Hospital and a co-author of the study, titled, “Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure.” Also, get a sneak peak at an episode of our members-only podcast Endocrine Feedback Loop which looks at a study in The Journal of Clinical Endocrinology & Metabolism about the glycemic gap in hospitalized patients with COVID. Show notes are available at https://www.endocrine.org/podcast/enp76-infants-and-in-utero-exposure-to-covid — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Host Aaron Lohr talks about thyroiditis and COVID-19 with Ilaria Muller, MD, PhD, from the University of Milan. Dr. Muller presented her research in March at ENDO 2021: “Early Follow-up of Atypical Thyroiditis Induced by SARS-CoV-2.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. Show notes are available at https://www.endocrine.org/podcast/enp65-type-1-diabetes-and-challenges-across-the-lifespan — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

As part of Women’s Health Month, we speak with Jerilynn Prior, who talks about a new treatment approach to perimenopause: oral, micronized progesterone. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Aaron talks with Deborah Kurrasch, PhD, associate professor at the University of Calgary, and Dinu Nesan, PhD, postdoctoral fellow also at University of Calgary. At the Endocrine Society's annual meeting in 2019, they presented research on BPA exposure's effects on circadian rhythms in mice during pregnancy. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We explore type 1 diabetes, everything from diagnosis to treatment strategies, hypoglycemia, technology, and teleheath. Host Aaron Lohr talks with Irl Hirsch, MD, from the University of Washington, and Davida Kruger, NP, from the Henry Ford Health System. They co-chair the Endocrine Society's 8th Annual Endocrine Fellows Type 1 Diabetes Care and Management Program. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

A new study in The Journal of Clinical Endocrinology & Metabolism shows the relationship between abnormal sodium levels and greater risk of respiratory failure and death in patients with COVID-19. Host Aaron Lohr speaks with two of the authors, Ploutarchos Tzoulis, MD, PhD, from University College London Medical School and Julian Waung, PhD, from the Whittington Health NHS Trust in London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr talks about cardiovascular disease and type 2 diabetes with Jonathan Purnell, MD, from Oregon Health & Science University. Dr. Purnell chaired the Endocrine Society's recent educational series, “Current and Future State of Cardiovascular Disease in Type 2 Diabetes,” which is available through December 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Caitlin talks about the European Union’s recent resolution on endocrine-disrupting chemicals. She is joined by Rémy Slama, PhD, an environmental epidemiologist and senior investigator at INSERM, France’s National Institute of Health and Medical Research, and Barbara Demeneix, PhD, professor in the Comparative Physiology Laboratory within the Natural History Museum in Paris. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The program covered a wealth of information, and host Aaron Lohr talks with Amy Rothberg, MD, DABOM, program chair and a clinical professor of internal medicine at the University of Michigan’s School of Public Health. If you weren’t able to attend the fellows program, we have a free series of on-demand lectures available online, and those are accredited. With thanks to Lilly USA LLC and Novo Nordisk for making both the obesity fellows program and this podcast episode possible through an unrestricted, educational grant. Show notes, including a link to the Endocrine Society Learning Center for earning ABIM points and AMA PRA Category 1 credits, are available at https://www.endocrine.org/podcast/enp81-obesity-fellows-program — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Today we celebrate 100 years since the discovery of insulin. We talk with Elizabeth A. Stephens, MD, an endocrinologist with the Providence Medical Group in Portland, Ore., about the importance of this landmark discovery, how it shaped our understanding and treatment of diabetes, and how it sets the stage for the exciting breakthroughs of tomorrow. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects on fetal and neonatal endocrine puberty. Host Aaron Lohr talks with Mary Bunnell from the University of Illinois Urbana-Champaign, co-author of the study, titled, “Prenatal Phthalate Exposure Alters the Pattern of Fetal and Neonatal Endocrine Puberty in a Sex-specific Manner.” Show notes are available at https://www.endocrine.org/podcast/enp77-phthalates-and-endocrine-puberty — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Host Aaron Lohr talks about vitamin D insufficiency and COVID-19 with Laurel Mohrmann, MD, and Sweta Chekuri, MD, both from Montefiore Medical Center in the Bronx. Drs. Mohrmann and Chekuri participated on a team that presented in March on vitamin D insufficiency at ENDO 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

The pandemic has changed the world of medical and science conferences, including the Endocrine Society's annual meeting, ENDO 2021, which will be an all-virtual event. Host Aaron Lohr talks with Felix Beuschlein, a professor at University Hospital Zurich and chair of the Society's annual meeting steering committee, about what to expect. ENDO 2021 will be held on March 20-23. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” Show notes are available at https://www.endocrine.org/podcast/enp63-vosoritide-and-children-with-genetic-short-stature — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

In another dispatch from ENDO 2023, host Aaron Lohr talks with Max Petersen, MD, PhD, from Washington University in St. Louis, about his team’s research presented at the meeting. Their presentation was titled, “Cellular Insights Into Metabolically Healthy and Unhealthy Obesity.” Show notes are available at https://www.endocrine.org/podcast/enp74-healthy-and-unhealthy-obesity — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

From ENDO 2023, host Aaron Lohr talks with Jayalakshmi Udayasankar, MD, from the Palo Alto Medical Foundation, about her team’s research presented at the meeting, titled, “Tingling Over Cheek: An Atypical Presentation of Invasive Fungal Sinusitis in an Ambulatory Patient With Type 2 Diabetes.” Show notes are available at https://www.endocrine.org/podcast/enp75-a-case-study-on-fungal-sinusitis-in-t2d — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Aaron welcomes back Maria Fleseriu, MD, from Oregon Health and Science University, this time to talk about the latest in acromegaly research and treatment. He also speaks with Marvin Avila, an acromegaly patient living in the Washington, DC, metro area. Endocrine Society members, for a chance to win a pituitary pin, please complete a survey at https://education.endocrine.org/acromegalypodcast (login required). This episode is supported by Pfizer through an unrestricted, educational grant. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We continue our special Women in Endocrinology series. Caitlin talks with Varykina Thackray, PhD, from the University of California, San Diego, about her 2018 article in JCEM about polycystic ovary syndrome and hyperandrogenism. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Caitlin talks with author and researcher Nayara Aquino, PhD, from the Federal University of Minas Gerais, Brazil, about her research on neuroendocrine control of the female reproductive system. Her paper, published in Endocrinology in June 2017, was selected for the Endocrine Society’s Women in Endocrinology Thematic Issue. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We talk with Stephanie Page, a professor of medicine at the University of Washington, about research on what she calls a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

We celebrate women in endocrinology by launching this podcast series, talking with authors of 12 influential, high-impact research papers representing the spectrum of basic through clinical research, geographical diversity and career stage, published in Endocrine Society journals since 2017. Here we speak with Stina Rikke Jensen, PhD, a researcher at Novozymes in Denmark. Her 2017 Endocrinology paper, on biological roles of insulin and its receptor in murine intestinal growth and function, is part of a special thematic collection of these 12 influential papers. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks with two researchers at ENDO 2023, Kyle Horlen, DVM, and Joshua Myers, both from Rani Therapeutics, about two presentations they made about an oral treatment of teriparatide for the treatment of osteoporosis. The two presentations are titled, “Pharmacokinetics (PK) and Pharmacodynamics (PD) of the Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered via an Orally Administered Robotic Pill (RT-102),” and “An Orally Administered Robotic Pill (RP) Reliably And Safely Delivers the Human Parathyroid Hormone Analog hPTH(1-34) (Teriparatide) With High Bioavailability in Healthy Human Volunteers: A Phase 1 Study.” Show notes are available at https://www.endocrine.org/podcast/enp73-a-robotic-teriparatide-pill-to-treat-osteoporosis — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

We talk with James Findling from the Medical College of Wisconsin about the debate surrounding the symptoms that some see as indicative of adrenal fatigue and failure and others see as a false positive for a condition that, in fact, does not exist. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.